Loading insider details...
Beta
Latest Form 4 (Mar 12, 2026): Sale of 44,173 NAMS shares, $1.34M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 12, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Sale | 44,173 | $1.34M |
| Mar 11, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Sale | 28,186 | $829.0K |
| Jan 10, 2026 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 3,400 | n/a |
| Jun 3, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Exercise/Conversion | 68 | n/a |
| May 2, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Exercise/Conversion | 69 | n/a |
| Apr 21, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Exercise/Conversion | 69 | n/a |
| Mar 28, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Exercise/Conversion | 3,102 | n/a |
| Jan 8, 2025 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 6,960 | n/a |
| Feb 21, 2024 | NewAmsterdam Pharma Co N.V. (NAMS) | Purchase | 5,000 | $95.0K |
| Jan 3, 2024 | NewAmsterdam Pharma Co N.V. (NAMS) | Grant/Award | 10,000 | n/a |